Retinal Degeneration Fund Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 3
Professionals
  • Investments
  • 8
  • Portfolio
  • 6
  • Exits
  • 1
Exits

Retinal Degeneration Fund General Information

Description

Founded in 2018, Retinal Degeneration Fund is a not-for-profit venture capital fund based in Raleigh, North Carolina. The firm seeks to make venture philanthropy investments in companies developing therapeutic technologies for inherited retinal diseases and macular degeneration.

Contact Information

Website
www.retinaldegenerationfund.org
Year Founded
2018
Investor Status
Actively Seeking New Investments
Primary Investor Type
Not-For-Profit Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 223 South West Street
  • Suite 900
  • Raleigh, NC
  • United States

Retinal Degeneration Fund Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Saliogen Therapeutics 05-Jan-2022 Early Stage VC 00000 Drug Discovery Generating Revenue
0000 00000000 20-Aug-2021 0000 00000 0000 Drug Discovery Startup 00000000 00000 00.0
000000 000 00 18-May-2021 00000 00000 0000 Therapeutic Devices Generating Revenue 00000000 00000 00.0
000000 00000000000 16-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000000 00000 00.0
000000 00000000000 01-Apr-2020 00000 00000 00.000 Drug Discovery Clinical Trials - Phase 1 00000000 00000 00.0
000000 000(0000000 27-Jun-2019 00000 00000 0000 Biotechnology Generating Revenue
Nayan Therapeutics 13-Feb-2019 Early Stage VC 000 Drug Discovery Startup
Nacuity Pharmaceuticals 20-Jul-2017 Early Stage VC 000.00 Drug Discovery Clinical Trials - General 00000000 00000 00.0
To view Retinal Degeneration Fund’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Retinal Degeneration Fund Exits (1)

Company Name Exit Date Exit Type Exit Size
000000 000(0000000 01-Sep-2020 000000000000000000 00000
To view Retinal Degeneration Fund’s complete exits history, request access »

Retinal Degeneration Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Retinal Degeneration Fund Team (3)

Name Title Deals Funds Boards Office
Benjamin Yerxa Ph.D Chief Executive Officer 0 0 Raleigh, NC
Jason Menzo Chief Operating Officer & President Raleigh, NC
Rusty Kelley Ph.D Senior Vice President, Investments & Alliances, Foundation Fighting Blindness 0 Raleigh, NC
To view Retinal Degeneration Fund’s complete team members history, request access »

Retinal Degeneration Fund Co-Investors (23)

Name With Exits Lead Partner Series Industry
Atlas Venture 2 0 0 Series chart Industry bar
Mission BioCapital 0 0 0 Series chart Industry bar
PBM Capital Group 0 0 Series chart Industry bar
Abingworth Management 0 0 Series chart Industry bar
T. Rowe Price 0 Series chart Industry bar
You’re viewing 5 of 23 co-investors. Get the full list »